Climate Drugs Pharma

Greenland’s hunting community reports high PFAS levels

HQ Team July 13, 2023: A hunting community, as far as Northeastern Greenland has some of the world’s highest concentrations of harmful polyfluoroalkyl.

Read More
Climate Drugs Pharma

Covid-19, summer heat, mpox challenges haunt European region

HQ Team June 28, 2023: Extreme summer heat and a resurgence of mpox in Europe are adding to the hardship created by the.

Read More
Drugs Health Medical Pharma

Japan’s Eisai seeks marketing nod for Alzheimer’s drug in South Korea

HQ Team June 8, 2023: Japan’s Eisai Co and Biogen Inc., have submitted a marketing authorisation application with the South Korean health authority.

Read More
Climate Health Medical Pharma

Situation in Europe’s largest nuclear plant remains ‘dangerous’: IAEA 

Europe’s largest nuclear plant, the Zaporizhzhya Nuclear Power Plant, in Ukraine, remains “extremely fragile and dangerous” because the war with Russia may escalate,.

Read More
Drugs Health Pharma

Astellas drug to treat menopausal hot flashes gets FDA’s green light

HQ Team May 14, 2023: Astellas Pharma, a Japanese drugmaker, announced that the FDA has approved its oral drug Veozah for the treatment.

Read More
Health Medical Pharma

Dutch court orders father of 550 kids to stop sperm donation

HQ Team April 29, 2023: The Hague District Court has stopped a man from donating sperm after he was alleged to have fathered.

Read More
Climate Health Medical

Alphabet signs pacts in Belgium, Netherlands for clean energy

HQ Team April 13, 2023: Alphabet Inc, Google’s parent company, has signed two new power purchase agreements in Belgium and the Netherlands to.

Read More
Drugs Medical Pharma

Antibiotic shortage forces EU to take measures

A group of European patient and consumer organisations has written a letter to the European Medicines Agency (EMA) expressing concern over the shortage.

Read More
Drugs Pharma

Glenmark’s heart failure treatment drug makes India debut

Glenmark Pharmaceuticals, an Indian multinational firm, has introduced its heart failure drug in the country, according to a company statement.

Read More
Drugs Pharma

Eiasi files market authorization for Alzheimer’s drug in Japan

Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.

Read More
X